| Date | Title | Description |
| 10.09.2026 | Google DeepMind открыла базу прогнозов влияния однонуклеотидных изменений в геноме человека | Google DeepMind открыла AlphaGenome Atlas — базу данных, позволяющую прогнозировать последствия любого возможного однонуклеотидного варианта в геноме человека. Для её формирования использовали ИИ‑модель AlphaGenome, чтобы рассчитать влияние... |
| 07.09.2026 | Nature Biotechnology | Insilico's AI-Driven IPF Candidate Rentosertib Shows Potential for Biological Age Reversal, as Assessed by Six Proteomic Aging Clocks | First-in-Class Evaluation of an AI-Driven Candidate: This is the first de-novo drug designed with generative AI for a de-novo target discovered using AI and Aging Research (AI aging clocks, AI models and Hallmarks of Aging Assessment).
Firs... |
| 24.08.2026 | AI Decodes DNA Switch That Starts 60 Percent of Human Genes; Mutations Now Assessable for Cancer | By Morris Robinson
Published: Aug 24 2026, 9:53 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 10.08.2026 | Inaugural ICBS Medal Honors Scientists Behind CRISPR, Topological Quantum Matter, and STORM Imaging | By Jackie Manning
Published: Aug 10 2026, 7:24 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 05.08.2026 | Inocras Fuels U.S. Precision Oncology Push with $31M Capital Infusion | Inocras, a San Diego bioinformatics leader, secured $31M in Series B-3 financing, raising its total capital to $100M. This investment fuels rapid U.S. expansion of its CLIA/CAP-certified whole-genome sequencing (WGS) and automated analytics... |
| 03.08.2026 | Inocras Closes $31M for Whole-Genome Bioinformatics Platform | What You Should Know
San Diego-based bioinformatics company Inocras Inc. closed an oversubscribed $31M Series B-3 financing round, bringing its total capital raised to approximately $100M.
The funding round was supported by strategic invest... |
| 26.06.2026 | Base Editing Maps Human Embryo Master Switch: NANOG Controls First Cell Fates | By Chase Fiorini
Published: Jun 26 2026, 3:29 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 15.05.2026 | The Boys’ V-One and Telepathy Plotlines Track Real Biotech and Neural-Privacy Crises Unfolding Now | By William Chan
Published: May 15 2026, 10:19 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 07.05.2026 | Pershing Square Sohn Cancer Research Alliance Doubles Funding Commitment, Awarding 13 Innovators In Cancer Research | The Pershing Square Sohn Cancer Research Alliance, a program of The Pershing Square Foundation, has announced 13 winners of the 2026 Pershing Square Sohn Cancer Prize, marking a transformative expansion of the program from a regional initia... |
| 21.04.2026 | Alzheimer’s research: Boston scientists find blood test can predict disease before symptoms | Getting your Trinity Audio player ready...
The secret might be hidden in our blood.
Boston researchers in a new study have found that a blood test can predict Alzheimer’s disease progression years before symptoms or brain scan changes. Rela... |
| 15.04.2026 | Base editing repairs mutation and liver function in mouse model of Zellweger spectrum disorder | The authors tested two different base editors in mice — one called ABE8e and a modified version called ABE8e-V106W — and found that both efficiently corrected the PEX1 mutation, but ABE8e-V106W was significantly better tolerated in the anim... |
| 10.04.2026 | Leukemia cells use a sugar-coated protein to hide from the immune system | Leukemia is adept at dodging the immune system, making it resistant to many of the newest generation of cancer immunotherapies. Now, researchers have identified a key part of the cancer’s disguise: a protein called CD43 on the surface of le... |
| 31.03.2026 | Scalable cell imaging method could help make drug safety testing faster, cheaper | Many drug candidates fail in early-stage clinical trials because of toxic effects in humans that weren’t seen in animal tests. Testing these chemicals in human cells in the lab could help detect these adverse effects sooner and at lower cos... |
| 31.03.2026 | How one family’s bipolar disorder experience led to more than $1 billion for the Broad Institute | Getting your Trinity Audio player ready...
By JAMES POLLARD
NEW YORK (AP) — Jon Stanley considers himself fortunate among bipolar disorder patients. He eventually responded to the right drug cocktail after self-described “full-brained mania... |
| 26.03.2026 | Malaria-transmitting mosquitoes in South America are evolving to evade insecticides | Anopheles darlingi mosquitoes — a major vector of malaria in South America—are evolving in response to insecticides, which may make them harder to kill and malaria more difficult to control, according to a new study led by Harvard T.H. Chan... |
| 25.03.2026 | Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs | The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing a ~20x increase in scale over existing data available in the world today
The Launch of STELA: Bioptimus is es... |
| 19.03.2026 | Mutation reveals connection between schizophrenia and brain circuit needed to incorporate new information | One of the symptoms of schizophrenia is difficulty incorporating new information about the world. This can lead people with schizophrenia to struggle with making decisions and, eventually, to lose touch with reality.
Neuroscientists from th... |
| 26.02.2026 | Study reveals genetic balancing act between autoimmunity and cancer risk | An autoimmune disorder that affects the thyroid gland, called autoimmune hypothyroidism (AIHT), is the most common autoimmune disease, yet it remains largely understudied.
New research from scientists at Broad Institute, University of Helsi... |
| 26.02.2026 | Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics | At AGBT, researchers reveal new findings from studies leveraging Illumina's multiomics solutions
SAN DIEGO, Feb. 26, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced new customer breakthroughs in oncology powered by Illumina's s... |
| 25.02.2026 | Scientists sharpen genetic maps to help pinpoint DNA changes that influence human health traits and disease risk | Scientists have identified how specific genetic changes function in cells to influence disease risk and other human health traits. By probing regions of DNA previously linked to disease, the work has created high resolution maps of DNA vari... |
| 25.02.2026 | Illumina launches TruPath Genome, setting a new standard in genomic insight | TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow
Data presented at AGBT demonstrates TruPath Genome's accuracy in detecting rare genetic disease
Broad Clinical Labs is among first to adopt product,... |
| 25.02.2026 | Free genetic testing program aims to improve medical care across Alabama | An initiative aimed at improving medical care and addressing chronic disease is now underway in Alabama. Catalyst, a precision medicine program led by the Alabama nonprofit Southern Research in collaboration with Broad Clinical Labs at the ... |
| 02.02.2026 | Feng Zhang inducted into National Inventors Hall of Fame | Broad Institute core member Feng Zhang, along with 15 other innovators, will be inducted into the National Inventors Hall of Fame. In partnership with the United States Patent and Trademark Office, the Hall of Fame will honor the latest cla... |
| 18.01.2026 | Scientists develop molecules that may treat Crohnâs disease | An estimated 3 million Americans have an inflammatory bowel disease (IBD) such as Crohnâs disease or ulcerative colitis. But a lucky few individuals are far less likely to develop IBD because they have a rare variant of a gene called CARD... |
| 16.01.2026 | Making U.S. biotech more competitive with China’s could help rare disease patients, experts say | To share your story, or find out how to get involved with CNBC Cures, email [email protected]
China is pumping money into its biotech industry, helping launch a new wave of labs and incubators in the country.
Experts say this could slow d... |
| 08.01.2026 | Researchers uncover molecular roots of fibrosis or tissue scarring in inflammatory bowel disease | When inflammation in the body goes unchecked, it can cause fibrosis, or tissue scarring that may lead to organ dysfunction or even failure. This can happen in conditions such as inflammatory bowel diseases (ulcerative colitis and Crohn’s di... |
| 25.12.2025 | Manifold Fuels Life Sciences AI with $18 Million Series B | Manifold raised $18 million in Series B funding, bringing its total to $40 million, to bolster its vertical AI platform for life sciences. Reach Capital led the round, backing Manifold's specialized "Agent OS" and secure, collabor... |
| 24.12.2025 | Manifold: $18 Million Series B Raised To Expand Vertical AI Platform For Life Sciences | Manifold, an AI platform focused on life sciences workflows from discovery through clinical and precision care, has raised $18 million in a Series B financing led by Reach Capital, with participation from SilverArc Capital, Industry Venture... |
| 23.12.2025 | High-fat diets make liver cells more likely to become cancerous | One of the biggest risk factors for developing liver cancer is a high-fat diet. A new study from MIT reveals how a fatty diet rewires liver cells and makes them more prone to becoming cancerous.
The researchers found that in response to a h... |
| 18.11.2025 | SOFR Academy Adds Chávez; Stocks Mixed Amid AI Doubts | SOFR Academy hires R. Martin Chávez. He's a financial tech expert. Stocks are mixed. AMD gains on AI hopes. Doubts linger about AI stock valuations.
Stocks showed mixed performance. The S&P 500 saw a slight dip. The Dow Jones Industrial... |
| 12.11.2025 | SOFR Academy Appoints R. Martin “Marty” Chávez as Senior Advisor | SOFR Academy, Inc., a leading financial engineering firm, today announced the appointment of R. Martin “Marty” Chávez as Senior Advisor. Widely regarded as one of the most influential figures at the intersection of finance, technology, and ... |
| 02.11.2025 | Genetic variant increases risk of heart muscle disease common in individuals of African ancestry | Dilated cardiomyopathy (DCM), a leading cause of heart failure, is twice as common in Black individuals as in white individuals. This excess risk is not fully explained by known risk factors such as high blood pressure or socioeconomic barr... |
| 02.11.2025 | Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain receive the 2025 Merkin Prize at the Broad Institute for chimeric antigen receptor (CAR) T-cell therapy | The 2025 Richard N. Merkin Prize in Biomedical Technology was jointly awarded to Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain in a ceremony and symposium at the Broad Institute on September 30, 2025. The prize, created by ... |
| 29.10.2025 | Valthos Raises $30M in Seed Financing | Valthos harnesses computational methods to characterize biological sequences and design adaptive countermeasures
Valthos, a San Francisco, CA-based AI biodefense startup, raised $30m in seed financing.
The round was led by OpenAI Startup Fu... |
| 27.10.2025 | Valthos: $30 Million Raised For Biotechnology Platform | Valthos, a newly launched biotech company, announced recently that it has emerged to safeguard humanity from the accelerating threat of programmable biology. In a company blog post, Valthos stated that as artificial intelligence continues t... |
| 16.10.2025 | Broad-Bayer collaboration leads to drug candidate for a hard-to-treat type of lung cancer | An alliance of scientists at the Broad Institute and Bayer Pharmaceuticals have developed a drug candidate, sevabertinib, that could be a new treatment for a group of lung cancer patients who have few options today.
In a new study published... |
| 15.10.2025 | Broad Clinical Labs sets new GUINNESS WORLD RECORDS™ title for fastest DNA sequencing technique | Broad Clinical Labs, in collaboration with Roche Sequencing Solutions and Boston Children’s Hospital, today announced official recognition by Guinness World Records for achieving the fastest DNA sequencing technique to date. Leveraging Roch... |
| 14.10.2025 | Crunch Lab: $5 Million Closed For Advancing Intelligence Layer for Decentralized AI | Crunch Lab, a key player in the CrunchDAO ecosystem, has successfully secured $5 million in a strategic funding round. This round was co-led by Galaxy Ventures and Road Capital, with additional support from VanEck and Multicoin. This latest... |
| 01.10.2025 | Jason Buenrostro named core institute member at Broad | Broad Institute has appointed Jason Buenrostro as a core institute member. Buenrostro, a leading epigenomics researcher and technology developer, will also join the leadership team of the Epigenomics Program at Broad.
Buenrostro is a profes... |
| 23.08.2025 | Breast cancer therapy can raise uterine cancer risk through a unique mechanism | Studies show that people receiving tamoxifen, a highly effective and commonly used therapy to treat breast cancer, face a 2- to 7-fold increased risk of developing uterine cancer within 2-5 years of tamoxifen treatment compared to the gener... |
| 08.08.2025 | Blood-based test provides new diagnostic approach for multiple myeloma | Researchers at Dana-Farber Cancer Institute, Massachusetts General Hospital (MGH), and the Broad Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions. ... |
| 07.08.2025 | Scientists develop technology that brings new precision to genome editing | The FDA’s recent approval of the first CRISPR-Cas9–based gene therapy marked a major milestone in biomedicine, validating genome editing as a promising treatment strategy for disorders like sickle cell disease, muscular dystrophy, and certa... |
| 06.08.2025 | Breathing low-oxygen air slows Parkinson’s progression in mice | Researchers from the Broad Institute and Mass General Brigham have shown that a low-oxygen environment — similar to the thin air found at Mount Everest base camp — can protect the brain and restore movement in mice with Parkinson’s-like dis... |
| 02.08.2025 | Genomics points to potential targeted treatment options for pediatric gliomas | A collaborative study between Dana-Farber Cancer Institute and the Broad Institute found that 8.9 percent of children with glioma, the most common form of pediatric brain tumor, have alterations in the fibroblast growth factor receptor (FGF... |
| 01.08.2025 | Study finds biomarkers, drug targets, risk factors for most common form of lung cancer | By analyzing tens of thousands of genes, proteins, and protein modifications in hundreds of lung tumors, an international research team has uncovered new factors linked to poor outcomes in lung adenocarcinoma in both smokers and people who ... |
| 30.07.2025 | Collaboration aims to reduce animal use in drug safety testing | Roughly a third of drug candidates fail in the first phase of clinical trials, often due to unanticipated toxic effects that weren’t apparent in animal tests. A consortium co-led by Broad Institute scientists is building tools and datasets ... |
| 25.06.2025 | Q&A: One scientist’s bold vision to make on-demand treatments routine for life-threatening rare genetic diseases | In May 2025, researchers announced that K.J. Muldoon, a baby boy born without the ability to process dietary protein properly, had become the first person to be treated with a customized gene editing therapy. Based on a technology developed... |
| 29.05.2025 | Making antibiotics more potent against drug-resistant bacteria | Researchers have created a pipeline for discovering unique combinations of molecules that increase the effectiveness of antibiotics against drug-resistant bacteria. The team, led by scientists at the Broad Institute and the Tufts University... |
| 27.05.2025 | Gene editing disrupts Huntington’s mutation in mice | Broad Institute researchers have developed a way to edit the genetic sequences at the root of Huntington’s disease and Friedreich’s ataxia.
The conditions are two of more than 40 severe neurological disorders caused by three-letter stretche... |
| 21.05.2025 | Genomic score predicts patients' progression to multiple myeloma | A new risk assessment score developed by researchers at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, and Massachusetts General Hospital reveals how multiple myeloma, a form of blood cancer, begins and progresses fro... |
| 21.05.2025 | Scientists create next generation of tools in battle against brain disease | Researchers from around 29 universities and institutions across North America have teamed up to create a large, versatile, and effective arsenal of new biological tools that will play a critical role in the battle against brain disease. The... |
| 14.05.2025 | AI tool predicts potential drug targets by analyzing cell images | A new AI model developed by researchers at the Eric and Wendy Schmidt Center at the Broad Institute and ETH Zurich’s Department of Health Science and Technology can identify genes that have been altered, such as ones that might be causing a... |
| 13.05.2025 | #WhyIScience Q&A: A systems biologist uses AI to understand how the genome controls cell fate | Growing up in the Sichuan province in China, Bo Xia was curious about the nature he saw around him: the creeks that ran through his hometown and its many animals and insects. In school, he loved imagining how molecules made up materials and... |
| 08.05.2025 | The Rise of AI and Regenerative Medicine: A New Era of Innovation | In the world of technology and healthcare, two stories are unfolding that promise to reshape our future. On one side, Google’s DeepMind has unveiled its latest coding model, Gemini 2.5 Pro I/O Edition. On the other, Stately Bio has secured ... |
| 08.05.2025 | How the Novo Nordisk Foundation Center at Broad is using scalable technologies and AI to find the root cause of diabetes | Since the earliest days of her scientific career, Melina Claussnitzer, a metabolic disease researcher at the Novo Nordisk Foundation Center for Genomic Mechanisms of Disease (NNFC) at the Broad Institute, has been thinking about how to acce... |
| 07.05.2025 | Stately Bio: $12 Million Closed For Developing Regenerative Medicines With Cellular Imaging Platform | Stately Bio, a company developing cell therapies using an ML-based live-cell imaging platform, announced $12 million in seed funding led by AIX Ventures, with participation from Dimension Capital, Foothill Ventures, Village Global, Caffeina... |
| 10.04.2025 | Potential Alzheimer’s disease therapeutic target identified in brain immune cells | Since the 1990s, researchers have found several immune system molecules that act like “brakes” on immune responses, leading to a new class of cancer drugs. One of these “immune checkpoint” molecules, called Tim-3 has recently been linked to... |
| 06.04.2025 | David Liu receives Breakthrough Prize in Life Sciences | Gene editing pioneer David Liu, a core member at the Broad Institute where he is the Richard Merkin Professor and director of the Merkin Institute for Transformative Technologies in Healthcare, has been named a laureate of the 2025 Breakthr... |
| 04.04.2025 | Scientists have developed a way to scale up spatial genomics and lower costs | Spatial transcriptomics technologies opened the door for new kinds of biological measurements, allowing scientists to generate detailed maps of where genes are expressed in tissue. But most methods rely on expensive and time-intensive imagi... |
| 28.03.2025 | A Novo Nordisk - Broad collaboration is connecting Denmark-based and Broad researchers | When Maddie Murphy, a computational associate at the Broad Institute of MIT and Harvard, first learned she’d have the opportunity to pursue her research in Copenhagen, she envisioned a two- or three-week visit. Then her supervisor, Ray Jone... |
| 12.03.2025 | New technology puts a spatial lens on CRISPR screening | Recently, scientists have been able to explore gene circuitry in individual cells using methods that suppress particular genes and measure the impact on the expression of other genes. These methods, however, fail to capture spatial informat... |
| 10.03.2025 | The Butter Battle: Plant Oils vs. Dairy Fats in the Quest for Longevity | In the world of nutrition, butter has long been a staple. It’s creamy, rich, and often seen as a culinary delight. But a new study suggests that this beloved dairy product may come with a hefty price tag: our health. Researchers from presti... |
| 10.03.2025 | Study: Consuming Plant-Based Oils Instead of Butter Could Significantly Reduce Mortality | A new study that analyzed data from over 200,000 people followed for more than 30 years has concluded that consuming plant-based oils instead of butter may have significant beneficial health effects.
Investigators from Mass General Brigham,... |
| 06.03.2025 | Studies reveal new genetic roots of atrial fibrillation | Two studies led by researchers at the Broad Institute of MIT and Harvard and Mass General Brigham have greatly expanded the number of known genetic variants that boost the risk for atrial fibrillation (AF), a common heart condition marked b... |
| 19.02.2025 | Alex Rives joins faculty of Broad Institute and MIT | Broad Institute of MIT and Harvard has appointed Alex Rives, a leading computer scientist and pioneering artificial intelligence researcher, as a core institute member. Rives will also serve as an assistant professor in the Department of El... |
| 06.02.2025 | Mutations in two gene pairs point to a promising drug target in 5 percent of adult cancers | Scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and Harvard and Columbia University have discovered that about 5 percent of adult cancers rely heavily on a gene called PELO to survive and that disabling the ... |
| 17.01.2025 | Health | Surprise finding sheds light on what causes Huntington’s disease, a devastating fatal brain disorder | Scientists at the Broad Institute of MIT and Harvard, McLean Hospital in Massachusetts and Harvard Medical School studied brain tissue donated by 53 people with Huntington’s and 50 without it, analyzing half a million cells.
They focused on... |
| 13.01.2025 | Broad Institute & Manifold Partner to Develop AI Research Platform | What You Should Know:
– The Broad Institute of MIT and Harvard is collaborating with Manifold, a leader in AI-powered research infrastructure, to develop a next-generation platform for biomedical research.
– The strategic partnership aims t... |
| 12.01.2025 | Prudentia Sciences: AI-Based Life Sciences Marketplace Company Raises $7 Million | Prudentia Sciences, an AI-based technology platform for life sciences, announced its public launch, supported by $7 million in funding. This funding round was led by GV, with participation from Iaso Ventures and Virtue.
The company aims to ... |
| 11.01.2025 | Prudentia Sciences: A New Dawn in Life Sciences Dealmaking | In the bustling corridors of Cambridge, Massachusetts, a new player is making waves in the life sciences arena. Prudentia Sciences has emerged with a mission: to revolutionize how biopharma companies navigate the complex world of drug devel... |
| 10.01.2025 | Scientists engineer CRISPR enzymes that evade the immune system | The core components of CRISPR-based genome-editing therapies are bacterial proteins called nucleases that can stimulate unwanted immune responses in people, increasing the chances of side effects and making these therapies potentially less ... |
| 09.01.2025 | Prudentia Sciences Launches with $7M in Funding to Transform the Life Sciences Marketplace for Dealmaking | CAMBRIDGE, Mass.–(BUSINESS WIRE)–January 9, 2025–
Prudentia Sciences, an AI-powered technology platform for life sciences announced today its public launch, supported by $7 million in funding. The funding round was led by GV, with participa... |
| 06.01.2025 | Researchers devise new way to target and correct disease-related proteins | Over the past two decades, large genetic studies have linked tens of thousands of DNA variants to thousands of human traits and diseases. Yet, correcting the effects of those variants to treat disease has been hampered in part by the lack o... |
| 09.12.2024 | Certis Oncology Launches AI-Powered Chatbot for Cancer Research | What You Should Know:
– Certis Oncology Solutions, a translational science and emerging technology leader in preclinical oncology research, is pleased to announce the commercial launch of CertisOI Assistant™, an innovative chatbot tool desi... |
| 21.11.2024 | Scientists find a region of the mouse gut tightly regulated by the immune system | The intestine maintains a delicate balance in the body, absorbing nutrients and water while maintaining a healthy relationship with the gut microbiome, but this equilibrium is disrupted in parts of the intestine in conditions such as celiac... |
| 04.11.2024 | Crowdfunded Wine-Making Supports Prostate Cancer Research - Drinking Charitably | Syrah grapes destined for the #2red Syrah-based Rhone-style blend
Tax-deductible crowd funded wine-making at 2redWinery supports prostate cancer research while backers receive award-winning wines.
GAINESVILLE, Fla., Nov. 4, 2024 /PRNewswire... |
| 01.11.2024 | CRISPR and Gene Editing: How Boston is Leading in Biotech | Share
Tweet
Share
Share
Email
Boston has become one of the top places for biotech research, and one of the big players in this space is CRISPR gene-editing technology. CRISPR is creating exciting opportunities in everything from medicine to... |
| 29.10.2024 | Massachusetts: The Beacon of Sustainable Biotech Innovation | Massachusetts is a powerhouse in biotechnology. It’s a state where innovation blooms like spring flowers. The rich soil of education, research, and collaboration nurtures groundbreaking advancements. This article explores how Massachusetts ... |
| 27.10.2024 | The Role of Massachusetts in Promoting Sustainable Biotech Solutions | Share
Tweet
Share
Share
Email
Massachusetts stands at the forefront of biotechnology innovation, particularly in sustainable solutions. With a rich history in education and research, this state has nurtured an ecosystem that fosters groundb... |
| 24.10.2024 | Count Me In and Genome Medical Partner to Provide Genetic Services to Patients Participating in Rare Cancer Research | Partnership provides genetic counseling and testing to patients participating in Osteosarcoma and Leiomyosarcoma Research
Diverse patient data is critical for the advancement of research and clinical trials, and the inclusion of genetic ser... |
| 23.10.2024 | Machine learning guides researchers to new synthetic genetic switches | Researchers at The Jackson Laboratory (JAX), the Broad Institute of MIT and Harvard, and Yale University, have used artificial intelligence to design thousands of new DNA switches that can precisely control the expression of a gene in diffe... |
| 22.10.2024 | New diagnostic approach for bacterial infections shows promise in the clinic | For patients with bacterial infections, the sooner they are treated with the appropriate antibiotics, the better they will fare. Current methods for determining which drugs might work for each patient rely on growing bacteria from the patie... |
| 18.10.2024 | City microbes surviving on disinfectants, research reveals | New research shows microbes are evolving to resist cleaners used to eliminate them. It also identifies novel strains living in Hong Kong that were previously only found in Antarctic desert soil.
SUZHOU, China, Oct. 18, 2024 /PRNewswire/ -- ... |
| 16.10.2024 | F. William Studier receives the 2024 Merkin Prize in ceremony at the Broad Institute for developing technology used to produce millions of doses of COVID-19 vaccines | The 2024 Richard N. Merkin Prize in Biomedical Technology was awarded to F. William Studier of Brookhaven National Laboratory in a ceremony and symposium at the Broad Institute on September 17, 2024. The prize, created by the Merkin Family ... |
| 09.10.2024 | Basecamp Research raises $60M Series B to fuel AI advancements in life sciences | Basecamp Research, an AI company dedicated to solving the most pressing challenges in the life sciences today announced it has completed a $60 million Series B financing led by Singular, bringing its funding to date to to $85 million.
Basec... |
| 30.09.2024 | Q&A: How Terra became a backbone of public health pathogen surveillance | DP: Before Terra, only a handful of state public health labs were analyzing their own genomic data. Most didn't really have a way to do large-scale genomic analysis well. Many relied on the CDC, a neighboring state lab, or an academic partn... |
| 23.09.2024 | New approach may yield modified messenger RNAs for treating a wide range of conditions | The life-saving use of messenger RNA (mRNA) in COVID-19 vaccines was a public example of the potential of mRNA-based therapies, which hold great promise for a wide range of treatment applications from cancer immunotherapy to gene editing.
W... |
| 16.09.2024 | Pioneering New Frontiers in ALS and Cancer Treatment: The Role of QRL-101 and mIDH1 Inhibitors | In the realm of medical science, innovation is the lifeblood that fuels progress. Two recent developments stand out: QurAlis Corporation's QRL-101 for ALS and Vazyme's contributions to mIDH1 cancer treatment. Both represent significant stri... |
| 16.09.2024 | Vazyme Leads Life Science Innovation, Boosting Research Breakthroughs in mIDH1 Cancer Treatment | NANJING, China, Sept. 16, 2024 /PRNewswire/ -- Vazyme (688105.SH), a leading life science technology company, significantly contributed to groundbreaking research published in Science Magazine through its innovative products. The study, whi... |
| 02.09.2024 | Робот-строитель, наблюдение за комарами и слизь кактусов: патенты университетов | Почти половина всех патентных заявок в России идут от вузов и образовательных центров. И среди них есть весьма оригинальные разработки. Рассказываем в нашей статье о патентной активности отечественных и зарубежных вузов.Пистолет для ран и и... |
| 20.08.2024 | #WhyIScience Q&A: A systems biologist develops computational tools to bring scale to cell experiments | At first, Yue Qin thought she wanted to become a doctor. She’d always been interested in disease — why people got sick, why some illnesses could send you to a hospital while others could be treated at home. As she grew older, however, she r... |
| 19.08.2024 | A common fatty acid may help restore healthy vaginal bacteria after infection | More than half of women globally experience bacterial vaginosis (BV) — an imbalance of naturally occurring microbes in the female genital tract — at least once in their life. The condition can cause painful symptoms and vaginal discharge, a... |
| 08.08.2024 | Machine learning approach helps researchers design better gene-delivery vehicles for gene therapy | Gene therapy could potentially cure genetic diseases but it remains a challenge to package and deliver new genes to specific cells safely and effectively. Existing methods of engineering one of the most commonly used gene-delivery vehicles,... |
| 07.08.2024 | Six scientists named as new core institute members at Broad | Broad Institute of MIT and Harvard has named six new core institute members: Gad Getz, Anna Greka, Nir Hacohen, Evan Macosko, Benjamin Neale, and Pardis Sabeti.
“We are thrilled to recognize these distinguished scientists for their track re... |
| 06.08.2024 | Andelyn Biosciences Expands AAV Curator™ Platform Offering to Include MyoAAV Plasmids through a License Agreement from the Broad Institute of MIT and Harvard | COLUMBUS, Ohio, Aug. 6, 2024 /PRNewswire/ -- Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has entered into a License Agreement with the Broad Inst... |
| 29.07.2024 | Predicta Biosciences: Pioneering a New Era in Cancer Diagnostics | Predicta Biosciences is making waves in the ocean of cancer diagnostics. With a fresh infusion of $5.2 million in seed funding, this Boston-based precision oncology company is poised to change the landscape of how we detect and treat blood ... |
| 27.07.2024 | Predicta Biosciences Raises $5.2 Million To Develop Novel Diagnostic And Therapeutic Products | Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic products, announced it had raised an oversubscribed $5.2 million seed round led by The Engine Ventures. And additional participating investors in... |
| 26.07.2024 | Researchers identify cheap and effective biomarkers for DCIS tumor stage | Ductal carcinoma in situ (DCIS), a pre-invasive tumor, accounts for about 25 percent of breast cancer diagnoses, a leading cause of cancer death. While doctors generally recommend treatment, they lack the appropriate evidence to reliably de... |
| 25.07.2024 | Q&A: How a stem cell bank is helping scientists understand psychiatric disorders | When Ralda Nehme, a cell biologist and neuroscientist, first started her lab at the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard in 2018, she realized a gap in the field. She was adept at growing stem ce... |
| 19.07.2024 | An immune factor in the brain plays critical roles in neuron function and aging | Immune cells in the central nervous system called microglia produce a protein called C1q, which helps the immune system prune synapses (the junctions between neurons) in the developing brain. A new study reveals that C1q can also enter neur... |
